Introducing the Youth Entrepreneurship Award finalists

With the EU celebrating the European Year of Skills, AmCham EU and JA Europe are pleased to announce the three finalists for the Youth Entrepreneurship Award 2023. The award, now in its 11th edition, recognises young people’s entrepreneurial spirit and aims to foster innovation in Europe. The finalists were selected from a pool of applicants from all over Europe. The winner will be selected by a high-level jury and announced on Wednesday, 28 June at AmCham EU’s Galaevening.

News

13 Jun 2023

HomePolicy and newsLibraryIntroducing the Youth Entrepreneurship Award finalists

The three outstanding finalists are:

MammoCheck

Entrepreneur: Alexandra Dimitriadou

Country of origin: Cyprus

With MammoCheck, women have a revolutionary tool for early detection of breast cancer in the palm of their hands. Advanced thermography technology combined with artificial intelligence allows women to proactively monitor and detect changes in their breast tissue, leading to better health outcomes and a higher quality of life. With a camera added to one’s phone, anyone can perform painless and accurate breast examinations, giving them the knowledge and awareness, they need to take control of their health.

Alexandra Dimitriadou is the Chief Executive Officer and Co-founder of MammoCheck.

AMIRA Meditech

Entrepreneur: Natalia Konova

Country of origin: Bulgaria

To fight antimicrobial resistance, AMIRA has developed a software solution to optimise antibiotic prescriptions in hospitals. By monitoring and controlling antibiotic usage, AMIRA helps doctors save time and decreases hospitals' resources. Through one-of-a-kind prediction models and more quickly adapting to the guidelines for treating infections, AMIRA seeks to preserve the effectiveness of antibiotics and save millions of lives. The algorithm is based on latest European and national guidelines for treating infections, as well as the legal documents of the antibiotics and each hospital's unique antibiotic resistance.

Chief Executive Officer and Co-founder Natalia Konova is a clinical pharmacologist at the Alexandrovska Hospital in Sofia, Bulgaria. She is also currently undertaking a PhD in improving the effectiveness and safety of antibiotics in hospital settings from Sofia’s Medical University’s Department of Pharmacology and Toxicology.

Drug n Drop

Entrepreneur: Alexia Vasilaki

Country of origin: Greece

Drug n Drop reports and communicates about pharmaceutical waste data along the supply chain to minimise medicinal waste. Through a complete smart system including hardware and software, Drug n Drop aims to optimise the production and management of medicine while managing the environmental and social issues caused by wasted medicines. It is able to produce reports and communicate them to all stakeholders of the pharmaceutical value chain.

Alexia Vasilaki is Co-founder and Chief Technology Officer of Drug n Drop and is executive assistant to the Chief Executive Officer at Junior Achievement Europe.

Join the conversation on social using #YEA2023

Related items

News

3 Sep 2026

Engaging with the Mexican Ambassador on stronger trade ties

On Wednesday, 2 September 2026, Malte Lohan, CEO, AmCham EU met with Esteban Moctezuma Barragán, Mexican Ambassador to the European Union, Belgium and Luxembourg, for an introductory meeting to exchange views on the transatlantic business relationship. Discussions focused on opportunities to deepen EU–Mexico economic ties following the signature of the Modernised Global Agreement and interim trade agreement earlier this year. AmCham EU looks forward to continued engagement with Ambassador Moctezuma and to supporting closer EU–Mexico economic cooperation.

Trade

News

27 Jul 2026

Turnberry Deal has brought a degree of predictability to transatlantic trade and investment, anniversary survey finds

Transatlantic

Position Paper

24 Jul 2026

Integrating the EU nexus approach into CS3D guidance

The European Commission’s forthcoming guidance on the Corporate Sustainability Due Diligence Directive (CS3D) should:

allow companies to voluntarily prioritise chains of activities with a meaningful connection, which should be further defined in the guidance, to the EU or based on a global risk-based approach in cases where companies have global integrated supply chains;
recognise that companies may face conflicting or overlapping legal requirements between EU and third-country legislation, particularly in relation to information gathering, audits, data transfers, supplier disengagement and cooperation with authorities;
clarify how companies should document and manage circumstances in which third-country law restricts or prevents a due diligence measure;
recognise interactions with competent local authorities, regulatory inspections, permits, licences and other official approvals as potentially relevant sources of due diligence information; and
protect companies from liability where they have followed a reasonable, documented and good-faith process, including where another stakeholder might have prioritised risks or selected due diligence measures differently.
If these measures are included in the guidance, they would help the CS3D deliver meaningful and effective due diligence, rather than an exhaustive mapping of every global business relationship. Flexibility, proportionality and legal certainty can help companies progressively develop credible global systems while directing resources towards the most significant risks and the areas where they have the greatest ability to achieve positive outcomes.

Learn more in our contribution and paper.

Corporate sustainability

Policy priorities

Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.

Discover our priorities

Membership

Connecting business and policymakers to strengthen the voice of American companies in Europe.

Become a member